Showing results (221-230 of 235) with videos related to
Sort By:
Pageof 24
The Journal of Clinical Investigation|June 28, 2022
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cellsRob S Sellar, Adam S Sperling, Mikołaj Słabicki, et al.Blood Cancer Discovery|March 5, 2024
Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple MyelomaIrene M Ghobrial, Nicole Gormley, Shaji K Kumar, et al.Nature Communications|January 11, 2022
Functional dissection of inherited non-coding variation influencing multiple myeloma riskRam Ajore, Abhishek Niroula, Maroulio Pertesi, et al.Blood Cancer Discovery|December 27, 2023
Acute Lymphoblastic Leukemia with Myeloid Mutations Is a High-Risk Disease Associated with Clonal HematopoiesisCaner Saygin, Pu Zhang, Jacob Stauber, et al.Molecular Cell|July 21, 2023
UBR5 forms ligand-dependent complexes on chromatin to regulate nuclear hormone receptor stabilityJonathan M Tsai, Jacob D Aguirre, Yen-Der Li, et al.Nature Communications|January 17, 2014
Heterogeneity of genomic evolution and mutational profiles in multiple myelomaNiccolo Bolli, Hervé Avet-Loiseau, David C Wedge, et al.Nature Medicine|April 20, 2026
Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trialOmar Nadeem, David M Cordas Dos Santos, Sarah Nikiforow, et al.Nature Communications|June 14, 2020
Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplantTarek H Mouhieddine, Adam S Sperling, Robert Redd, et al.The Journal of Molecular Diagnostics : JMD|September 27, 2025
Analytical Validation of a Pan-Cancer Next-Generation Sequencing Assay for In-House Liquid Biopsy Testing: An International Multicenter StudyGaëlle Lescuyer, Alexandre Harlé, Hari Shankar Kumar, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2025
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaHervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, et al.Pageof 24